Cancer survival in Africa, Asia, the Caribbean and Central America (SurvCan)

You are here: Home / Statistics / Comparative statistics by registry

Comparative statistics by cancer registry

Table2a: Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site

(Mumbai, India, 1992-1994 cases followed through 1999 and 1995-1999 cases followed-up until 2003)

Click on cancer site (ICD-10 code) for comparison

Site	ICD-10	No. of cases included	Complete FU		Incomplete FU: loss to FU						% with Complete FU at 5 years	Median FU (in months)
			Alive/dead	At end of FU	No.	%	% lost to FU: years from diagnosis
			No.	%	No.	%	<1	1-3	3-5	>5
C00	Lip	161	109	67.7	52	32.3	12.5	1.2	0.6	18.0	85.7	50.9
C01-02	Tongue	2106	1766	83.9	340	16.1	9.4	0.4	0.0	6.3	90.2	11.3
C03-06	Oral cavity	2769	2205	79.6	564	20.4	11.1	0.3	0.1	8.9	88.5	12.7
C09	Tonsil	513	447	87.1	66	12.9	8.6	0.8	0.0	3.5	90.6	8.3
C10	Other oropharynx	243	210	86.4	33	13.6	9.9	0.0	0.0	3.7	90.1	10.1
C11	Nasopharynx	243	213	87.7	30	12.3	7.4	0.4	0.0	4.5	92.2	12.5
C12-13	Hypopharynx	1902	1621	85.2	281	14.8	9.3	0.2	0.3	5.0	90.2	8.3
C15	Oesophagus	3128	2759	88.2	369	11.8	7.5	0.4	0.2	3.7	91.9	5.0
C16	Stomach	2205	1950	88.4	255	11.6	7.9	0.3	0.1	3.3	91.7	3.4
C18	Colon	1578	1315	83.3	263	16.7	9.2	0.2	0.1	7.2	90.6	8.4
C19-20	Rectum	1217	963	79.1	254	20.9	12.0	0.5	0.3	8.1	87.2	11.7
C21	Anus	220	164	74.5	56	25.5	14.1	0.0	0.9	10.5	85.0	12.2
C25	Pancreas	917	803	87.6	114	12.4	5.3	0.2	4.7	2.2	89.7	1.6
C32	Larynx	1880	1501	79.8	379	20.2	11.0	0.5	0.4	8.3	88.1	12.4
C33-34	Lung	3451	3102	89.9	349	10.1	6.4	0.3	0.5	2.9	92.8	3.0
C50	Breast	7294	5460	74.9	1834	25.1	12.2	0.3	0.3	12.3	87.2	30.9
C53	Cervix	4436	3290	74.2	1146	25.8	14.1	0.2	0.3	11.2	85.3	25.1
C56	Ovary	2029	1713	84.4	316	15.6	10.0	0.1	0.2	5.3	89.7	7.1
C60	Penis	327	234	71.6	93	28.4	15.9	1.8	0.6	10.1	81.7	20.3
C61	Prostate	1463	1194	81.6	269	18.4	13.4	0.1	0.2	4.7	86.3	13.2
C62	Testis	383	285	74.4	98	25.6	9.9	0.3	0.5	14.9	89.3	36.1
C64	Kidney	819	625	76.3	194	23.7	13.4	1.7	0.4	8.2	84.5	7.1
C67	Urinary bladder	1307	1000	76.5	307	23.5	13.6	1.1	0.8	8.0	84.5	16.5
C81	Hodgkin lymphoma	528	379	71.8	149	28.2	13.2	1.7	0.4	12.9	84.7	29.4
C82-85+C96	Non-Hodgkin lymphoma	2338	1906	81.5	432	18.5	9.9	0.4	0.7	7.5	89.0	5.9
C91	Lymphoid leukaemia	1099	947	86.2	152	13.8	8.8	1.0	0.5	3.5	89.7	1.5
C92-94	Myeloid leukaemia	1261	1124	89.1	137	10.9	7.7	0.7	0.3	2.2	91.4	1.0
C95	Leukaemia unspecified	345	312	90.4	33	9.6	6.2	1.4	0.6	1.4	91.9	0.3

Other tables available for this registry:

- Table1:	Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site (Mumbai, India, 1992-1994 cases followed through 1999 and 1995-1999 cases followed-up until 2003)
- Table2a:	Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site (Mumbai, India, 1992-1994 cases followed through 1999 and 1995-1999 cases followed-up until 2003)
- Table3:	Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site (Mumbai, India, 1992-1994 cases followed through 1999 and 1995-1999 cases followed-up until 2003)
- Table4:	Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group (Mumbai, India, 1992-1994 cases followed through 1999 and 1995-1999 cases followed-up until 2003)
- Table5b:	Proportion (%) of cases and 5-year absolute survival by extent of disease and site (Mumbai, India, 1992-1999)
- Table6:	Comparison of 5-year absolute and relative survival of cases diagnosed between 1982-1986 and 1992-1999 (Mumbai, India)

Registry chapter:

Consult the chapter in Cancer survival in developping countries (Volume II)